NASDAQ:AMEH Apollo Medical - AMEH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Apollo Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $39.05 +0.86 (+2.25%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$38.35▼$39.6450-Day Range$32.65▼$39.6652-Week Range$26.89▼$58.00Volume153,075 shsAverage Volume181,201 shsMarket Capitalization$2.24 billionP/E Ratio36.84Dividend YieldN/APrice Target$58.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Apollo Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside49.8% Upside$58.50 Price TargetShort InterestBearish8.13% of Float Sold ShortDividend StrengthN/ASustainability-0.69Upright™ Environmental ScoreNews Sentiment1.35Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth21.00%From $1.00 to $1.21 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.64 out of 5 starsMedical Sector196th out of 995 stocksManagement Consulting Services Industry10th out of 17 stocks 3.3 Analyst's Opinion Consensus RatingApollo Medical has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $58.50, Apollo Medical has a forecasted upside of 49.8% from its current price of $39.05.Amount of Analyst CoverageApollo Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted8.13% of the float of Apollo Medical has been sold short.Short Interest Ratio / Days to CoverApollo Medical has a short interest ratio ("days to cover") of 19.5, which indicates bearish sentiment.Change versus previous monthShort interest in Apollo Medical has recently decreased by 5.15%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldApollo Medical does not currently pay a dividend.Dividend GrowthApollo Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreApollo Medical has received a 64.92% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Health care management software" and "Management consulting for medical care" products. See details.Environmental SustainabilityThe Environmental Impact score for Apollo Medical is -0.69. Previous Next 3.0 News and Social Media Coverage News SentimentApollo Medical has a news sentiment score of 1.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Apollo Medical this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for AMEH on MarketBeat in the last 30 days. This is a decrease of -70% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Apollo Medical insiders have not sold or bought any company stock.Percentage Held by Insiders11.51% of the stock of Apollo Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 34.91% of the stock of Apollo Medical is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Apollo Medical are expected to grow by 21.00% in the coming year, from $1.00 to $1.21 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apollo Medical is 36.84, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.87.Price to Earnings Ratio vs. SectorThe P/E ratio of Apollo Medical is 36.84, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 154.15.Price to Book Value per Share RatioApollo Medical has a P/B Ratio of 3.99. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Apollo Medical (NASDAQ:AMEH) StockApollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company, which engages in the provision of care coordination services and a healthcare delivery platform. The company was founded on November 1, 1985 and is headquartered in Alhambra, CA.Read More Receive AMEH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AMEH Stock News HeadlinesMarch 25, 2023 | finance.yahoo.comFollowing a 20% decline over last year, recent gains may please Apollo Medical Holdings, Inc. (NASDAQ:AMEH) institutional ownersFebruary 26, 2023 | seekingalpha.comApollo Medical Holdings Inc. (AMEH) Q4 2022 Earnings Call TranscriptMarch 28, 2023 | Weiss Ratings (Ad)Fed's Shocking New Plan to Control Your MoneyThe Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. February 26, 2023 | finance.yahoo.comApollo Medical Holdings, Inc. (NASDAQ:AMEH) Q4 2022 Earnings Call TranscriptFebruary 25, 2023 | seekingalpha.comApollo Medical beats Q4 top and bottom line estimates; initiates FY23 outlookFebruary 16, 2023 | reuters.comIndia's Apollo Hospitals aims to make pharmacy business profitable in a year - CFO (Feb. 15)February 9, 2023 | finance.yahoo.comApollo Medical Holdings, Inc. Schedules 2022 Fourth Quarter and Year-end Financial Results Release and Conference CallJanuary 18, 2023 | finance.yahoo.comAnalysts Initiate Coverage: 4 Stocks to Buy for Higher ReturnMarch 28, 2023 | Weiss Ratings (Ad)Fed's Shocking New Plan to Control Your MoneyThe Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. January 6, 2023 | finance.yahoo.comApollo Medical Holdings, Inc. (AMEH) Gains But Lags Market: What You Should KnowJanuary 5, 2023 | tmcnet.comApollo Medical Holdings, Inc. Announces APA ACO AchievedJanuary 5, 2023 | finance.yahoo.comApollo Medical Holdings, Inc. Announces APA ACO Achieved $48.8 Million in Shared Savings from Centers for Medicare and Medicaid Services for 2021 Performance YearDecember 20, 2022 | msn.comApollo Hospital issues NCDs through private placement on NSEDecember 20, 2022 | finance.yahoo.comApollo Medical Holdings, Inc. to Participate in 41st Annual J.P. Morgan Healthcare ConferenceDecember 16, 2022 | msn.comMeet The Aerospace Engineer Who Saved Apollo 13 While Giving Birth To Jack BlackDecember 15, 2022 | msn.comApollo Medical in up to $50M share buyback programNovember 29, 2022 | marketwatch.comApollo Endosurgery Shares Hit 52-Week High on Boston Scientific Deal >APENNovember 25, 2022 | nasdaq.comIs the Options Market Predicting a Spike in Apollo Medical (AMEH) Stock?November 14, 2022 | finance.yahoo.comAre Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?November 8, 2022 | msn.comElection Day Is Here: Which Politicians Are Profiting (Or Losing) On Stocks?November 4, 2022 | seekingalpha.comApollo Medical Holdings, Inc. (AMEH) Q3 2022 Earnings Call TranscriptNovember 1, 2022 | msn.comApollo Endosurgery, Inc. (APEN) Reports Q3 Loss, Tops Revenue EstimatesOctober 19, 2022 | foxnews.comApollo 9 commander, astronaut James McDivitt, dies at age 93September 21, 2022 | seekingalpha.comHot Stocks: Travel stocks fall; AMEH, FREY rise on upgrades; SHC drops; XPEV sets 52-week lowSeptember 21, 2022 | msn.comGeneral Mills, Apollo Medical And Some Other Big Stocks Moving Higher On WednesdaySeptember 21, 2022 | seekingalpha.comApollo Medical gains after William Blair starts with outperform, touts operating modelSeptember 5, 2022 | finance.yahoo.comDoes Apollo Medical Holdings (NASDAQ:AMEH) Deserve A Spot On Your Watchlist?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AMEH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AMEH Company Calendar Last Earnings11/04/2021Today3/27/2023Next Earnings (Estimated)5/04/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Management consulting services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AMEH CUSIPN/A CIK1083446 Webwww.apollomed.net Phone(626) 282-0288Fax818-839-5190Employees1,362Year FoundedN/APrice Target and Rating Average Stock Price Forecast$58.50 High Stock Price Forecast$60.00 Low Stock Price Forecast$57.00 Forecasted Upside/Downside+49.8%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$1.06 Trailing P/E Ratio36.84 Forward P/E Ratio39.05 P/E GrowthN/ANet Income$49.05 million Net Margins4.29% Pretax Margin7.57% Return on Equity10.37% Return on Assets5.59% Debt Debt-to-Equity Ratio0.37 Current Ratio2.95 Quick Ratio2.95 Sales & Book Value Annual Sales$1.14 billion Price / Sales1.96 Cash Flow$1.28 per share Price / Cash Flow30.42 Book Value$9.78 per share Price / Book3.99Miscellaneous Outstanding Shares57,440,000Free Float50,824,000Market Cap$2.24 billion OptionableNot Optionable Beta0.77 Social Links Key ExecutivesThomas S. LamPresident, Co-Chief Executive Officer & DirectorBrandon SimCo-Chief Executive OfficerRita PewVice President-Strategy & OperationsChan BashoChief Financial & Strategy OfficerAlbert YoungChief Administration OfficerKey CompetitorsCorcept TherapeuticsNASDAQ:CORTBeam TherapeuticsNASDAQ:BEAMInsmedNASDAQ:INSMMirati TherapeuticsNASDAQ:MRTXPacific Biosciences of CaliforniaNASDAQ:PACBView All CompetitorsInsiders & InstitutionsVoya Investment Management LLCSold 2,622 shares on 2/28/2023Ownership: 0.026%Legal & General Group PlcBought 3,275 shares on 2/15/2023Ownership: 0.174%Schonfeld Strategic Advisors LLCBought 6,061 shares on 2/15/2023Ownership: 0.057%Algert Global LLCSold 2,040 shares on 2/15/2023Ownership: 0.023%Vestcor IncBought 8,636 shares on 2/15/2023Ownership: 0.015%View All Insider TransactionsView All Institutional Transactions AMEH Stock - Frequently Asked Questions Should I buy or sell Apollo Medical stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMEH shares. View AMEH analyst ratings or view top-rated stocks. What is Apollo Medical's stock price forecast for 2023? 3 equities research analysts have issued twelve-month target prices for Apollo Medical's shares. Their AMEH share price forecasts range from $57.00 to $60.00. On average, they anticipate the company's share price to reach $58.50 in the next twelve months. This suggests a possible upside of 49.8% from the stock's current price. View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts. How have AMEH shares performed in 2023? Apollo Medical's stock was trading at $29.59 on January 1st, 2023. Since then, AMEH shares have increased by 32.0% and is now trading at $39.05. View the best growth stocks for 2023 here. Are investors shorting Apollo Medical? Apollo Medical saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 3,500,000 shares, a decline of 5.1% from the February 28th total of 3,690,000 shares. Based on an average daily trading volume, of 179,400 shares, the days-to-cover ratio is currently 19.5 days. Approximately 8.1% of the shares of the stock are short sold. View Apollo Medical's Short Interest. When is Apollo Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023. View our AMEH earnings forecast. How were Apollo Medical's earnings last quarter? Apollo Medical Holdings, Inc. (NASDAQ:AMEH) issued its earnings results on Thursday, November, 4th. The company reported $0.69 EPS for the quarter, beating analysts' consensus estimates of $0.34 by $0.35. The firm earned $227.12 million during the quarter. Apollo Medical had a net margin of 4.29% and a trailing twelve-month return on equity of 10.37%. During the same quarter in the previous year, the business earned $0.45 earnings per share. What ETFs hold Apollo Medical's stock? ETFs with the largest weight of Apollo Medical (NASDAQ:AMEH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Quality ETF (XSHQ), Syntax Stratified SmallCap ETF (SSLY), iShares S&P Small-Cap 600 Value ETF (IJS), SPDR S&P 600 Small CapValue ETF (SLYV) and iShares U.S. Healthcare Providers ETF (IHF). What guidance has Apollo Medical issued on next quarter's earnings? Apollo Medical updated its FY 2023 earnings guidance on Thursday, February, 23rd. The company provided EPS guidance of $0.95-$1.20 for the period, compared to the consensus EPS estimate of $0.97. The company issued revenue guidance of $1.30 billion-$1.50 billion, compared to the consensus revenue estimate of $1.23 billion. What is Thomas Lam's approval rating as Apollo Medical's CEO? 15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend. What other stocks do shareholders of Apollo Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM). What is Apollo Medical's stock symbol? Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH." Who are Apollo Medical's major shareholders? Apollo Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Geode Capital Management LLC (1.34%), Dimensional Fund Advisors LP (0.72%), Charles Schwab Investment Management Inc. (0.53%), Principal Financial Group Inc. (0.44%), Morgan Stanley (0.43%) and Legal & General Group Plc (0.17%). Insiders that own company stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, Linda Marsh, Physicians Of Californi Allied and Thomas S Lam. View institutional ownership trends. How do I buy shares of Apollo Medical? Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Apollo Medical's stock price today? One share of AMEH stock can currently be purchased for approximately $39.05. How much money does Apollo Medical make? Apollo Medical (NASDAQ:AMEH) has a market capitalization of $2.24 billion and generates $1.14 billion in revenue each year. The company earns $49.05 million in net income (profit) each year or $1.06 on an earnings per share basis. How many employees does Apollo Medical have? The company employs 1,362 workers across the globe. Does Apollo Medical have any subsidiaries? The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc..Read More How can I contact Apollo Medical? Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 282-0288, via email at investors@apollomed.net, or via fax at 818-839-5190. This page (NASDAQ:AMEH) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.